Chandrasekhar Satishchandran 4

What Happened

• Chandrasekhar Satishchandran, a director of Ocugen, Inc. (OCGN), received a derivative grant on 2026-06-11 for 170,100 shares. The filing lists an acquisition price of $0.00 (an award/option-type grant), so no cash was paid by the insider at grant.
• This is a compensation award (not a purchase or sale) and does not represent an immediate market purchase or cash proceeds.

Key Details

• Transaction date and type: 2026-06-11 — Code A (Grant/Award of derivative securities).
• Security and amount: 170,100 derivative shares; reported price per share: $0.00.
• Vesting: Per the filing footnote, the option vests upon the earlier of (a) June 11, 2027 or (b) Ocugen’s next annual meeting of stockholders, subject to the insider’s continued service.
• Shares owned after transaction: Not specified in this Form 4.
• Filing timeliness: Reported on 2026-06-15; this meets the Form 4 two-business-day filing requirement (timely).

Context

• This was a standard equity compensation award to a director rather than an open-market purchase or sale. Such grants are commonly used for director compensation and typically vest over time. Because the award vests in the future, it does not reflect an immediate change in market exposure (no immediate sale or cashless exercise reported).